Today: 11 June 2026
10% yield play on Lululemon draws options interest as SM Energy tops investor search lists
1 January 2026
2 mins read

10% yield play on Lululemon draws options interest as SM Energy tops investor search lists

NEW YORK, December 31, 2025, 19:49 ET

  • A Trefis note outlined a put-options trade targeting roughly a 10% annualized yield while waiting to buy Lululemon at a lower price.
  • A TheStreet Pro note flagged Lululemon’s forward valuation as below the S&P 500’s multiple, citing Birinyi Associates.
  • Zacks said SM Energy has been among its most-searched stocks, while earnings estimates for the quarter moved lower.

A new options trade pitch targeting about a 10% annualized return is putting Lululemon Athletica back on investors’ screens as the stock trades far below its highs.

The setup matters now because investors are trying to balance two competing forces: bargain hunting after sharp drawdowns and the appeal of cash-like returns that can be earned while waiting.

It also shows how options — once mainly the domain of professionals — are increasingly being used as a “paid waiting” strategy, especially when shares are volatile and valuations are in focus.

Trefis said Lululemon (LULU) was trading around $210.67 a share and about 50% below its 52-week high, and outlined selling a put option with a $150 strike expiring Dec. 18, 2026. The note said the seller would collect about $940 per contract and, combined with a roughly 4% yield on cash held aside, target a total yield of about 10.5%.

A put option gives the buyer the right to sell shares at a set price by a set date. Selling that put collects a premium upfront, but it can obligate the seller to buy shares at the strike price if the stock falls below it.

A separate TheStreet Pro note said Lululemon now trades at about 16.3 times 12-month forward earnings versus about 22.3 times for the S&P 500, citing Birinyi Associates.

Lululemon has been caught between slowing demand in parts of the U.S. and intensifying competition in athletic and lifestyle apparel, a category dominated by global players and a growing list of newer brands.

The company is also heading into 2026 with fresh governance pressure. Lululemon founder Dennis “Chip” Wilson, in U.S. proxy materials filed on Dec. 30, said, “It is clear to the world that lululemon is special, but in need of change,” as he backed director nominees for the 2026 annual meeting. Streetinsider

A proxy fight is a campaign to persuade shareholders to vote for board changes, often raising uncertainty around leadership and strategy — and sometimes increasing short-term volatility in a stock.

In energy, SM Energy (SM) has been among the most searched-for stocks on Zacks.com lately, Zacks Equity Research said. Zacks said SM shares returned -3.8% over the past month versus a +0.8% change for the Zacks S&P 500 composite, while its U.S. oil-and-gas exploration and production industry group fell 3.7%.

Zacks said SM was expected to post quarterly earnings of $0.89 per share, with the consensus estimate down 4.8% over the last 30 days, and it rated the stock a Zacks Rank #3 (Hold). Zacks also said SM carried a Value Style Score of “A,” indicating it trades at a discount to peers. Finviz

The mix of option-income pitches, valuation debates and online search spikes underscores how investors are starting 2026 by leaning on screens and short-term signals — while keeping an eye on entry prices in beaten-down names.

Stock Market Today

  • SpaceX IPO Set for Historic $1.77 Trillion Launch Amid Valuation Doubts
    June 11, 2026, 8:50 AM EDT. SpaceX's planned $1.77 trillion IPO, aiming to raise $75 billion at $135 per share, faces skepticism from analysts who value the stock at about half that price. The shares will start trading on NASDAQ under the ticker SPCX on June 12. Elon Musk's valuation claims, including a $1.6 trillion addressable market, are challenged by Morningstar, which estimates the market at $129 billion. The IPO's scale is unprecedented, with 23 banks involved, restricting independent pre-IPO research. Meanwhile, U.S. tech stocks, including Tesla, suffered declines amid inflation concerns, but futures indicate slight gains. Goldman Sachs remains optimistic on the S&P 500, projecting an 8,000 year-end level despite volatility. Oracle shares fell over 7% before the bell after announcing increased capital expenditures and new fundraising plans. U.S. inflation at 4.2% supports expectations for the Federal Reserve to pause rate hikes next week.

Latest articles

Diesel Slips Again; Truckers Worry About What’s Next

Diesel Slips Again; Truckers Worry About What’s Next

11 June 2026
U.S. retail diesel prices dropped for the fifth straight week to $5.210 a gallon, down 14 cents but still $1.739 higher than last year, as crude and distillate inventories fell and traders warned that supply remains tight, raising risks that the recent price relief for freight and agriculture could reverse quickly.
D-Wave Tumbles 50%: QBTS Investors Confront Valuation

D-Wave Tumbles 50%: QBTS Investors Confront Valuation

11 June 2026
D-Wave Quantum shares plunged nearly 9% to $23.25—half their 52-week high—as investors question whether soaring bookings, up 1,994% to $33.4 million, can offset an 81% revenue drop and a $8.84 billion market cap against $12.4 million in trailing revenue; B. Riley raised its price target to $40, but the stock remains volatile amid sector-wide profit-taking and doubts over commercial adoption.
Nu Holdings stock steadies after $1 billion buyback move

Nu Holdings stock steadies after $1 billion buyback move

11 June 2026
Nu Holdings remains near its 52-week low despite a newly approved $1 billion share buyback, as analyst downgrades cite margin pressure, rising credit costs, and a CFO transition; investors are watching if the buyback can offset concerns after non-performing loans rose to 5% and credit loss allowances jumped 33% last quarter.
Why FICO Stock Is Sliding Today: Fair Isaac Drops in Thin Year-End Trading
Previous Story

Why FICO Stock Is Sliding Today: Fair Isaac Drops in Thin Year-End Trading

Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD
Next Story

Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD

Go toTop